semaglutide and mash Resmetirom GLP-1 agonists for MASH: complementary rather than exclusive Mechanism of Semaglutide in MASLD

Clinicians should consider common differentials (e.g., dietary triggers, small intestinal bacterial overgrowth, irritable bowel syndrome) before attributing new or worsening symptoms to either tirzepatide or histamine intolerance

All prescribing decisions are made at the sole discretion of your independent licensed healthcare provider

The active component in Wegovy (semaglutide) has been around for much longer than tirzepatide, so Wegovy has more accumulated long-term evidence, including the SELECT cardiovascular outcome data

"There are now effective drugs, and this could lead to higher labor productivity, gains in longevity, and potentially reduce medical costs costs elsewhere in the health system." Columbia Threadneedle Investments reported that the weight-loss drug industry could become a $1.7 trillion annual market if 100 million Americans took GLP-1s at their current price

Heavy alcohol use is also a risk factor for lactic acidosis with metformin